Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Influenza Virus Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00992784
What this trial is testing

Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' Influenza Vaccine in Elderly People

Who this might be right for
Influenza
GlaxoSmithKline 370
Post-approval studies (Phase 4)Study completedNCT06987942
What this trial is testing

Simultaneous Administration Study of Varicella Attenuated Live Vaccine and Trivalent Inactivated Influenza Vaccine (Split Virion)

Who this might be right for
VaricellaInfluenza Vaccine
Sinovac (Dalian) Vaccine Technology Co., Ltd. 899
Early research (Phase 1)Study completedNCT01368029
What this trial is testing

Safety of Lactobacillus Rhamnosus GG Vs. Placebo in Elderly Subjects Receiving Trivalent Inactivated Influenza Vaccine

Who this might be right for
HealthyElderly
Massachusetts General Hospital 28
Not applicableStudy completedNCT01306773
What this trial is testing

Convalescent Plasma Treatment in Severe 2009 H1N1 Infection

Who this might be right for
Influenza A
The University of Hong Kong 80
Not applicableStudy completedNCT01107262
What this trial is testing

Avian Influenza Studies In Lebanon

Who this might be right for
Avian InfluenzaVirus Diseases
St. Jude Children's Research Hospital 250
Early research (Phase 1)Study completedNCT01096056
What this trial is testing

Trial to Evaluate the Safety and the Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in Healthy Children

Who this might be right for
Influenza
GlaxoSmithKline 40
Early research (Phase 1)Study completedNCT01164553
What this trial is testing

Comparison of Flu Vaccine Doses in Children

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 243
Very early researchLooking for participantsNCT06664151
What this trial is testing

Window of Opportunity Trial of Intratumoral Seasonal Influenza Immunization in Cutaneous Squamous Cell Carcinoma (CSCC) Patients Awaiting Curative Excision

Who this might be right for
Skin CancerCutaneous Squamous Cell Carcinoma (CSCC)Cutaneous Squamous Cell Cancer
Dana-Farber Cancer Institute 25
Early research (Phase 1)Study completedNCT00660257
What this trial is testing

Safety and Immunogenicity of Booster Dose of An Inactivated,Adjuvanted Whole-Virion Pandemic Influenza(H5N1)Vaccine

Who this might be right for
Pandemic Influenza VaccinePreventionPandemic Influenza
Sinovac Biotech Co., Ltd 57
Large-scale testing (Phase 3)Study completedNCT01153685
What this trial is testing

Immunogenicity & Safety Study of Fluviral® (2010 - 2011 Season) in Adults Aged 18 to 60 Years and Over 60 Years

Who this might be right for
Influenza
GlaxoSmithKline 120
Not applicableStudy completedNCT03415425
What this trial is testing

Optimizing the Influenza Clinical Decision Support Tool

Who this might be right for
Clinical Decision Support
NYU Langone Health 25,881
Large-scale testing (Phase 3)Study completedNCT01229397
What this trial is testing

Immunogenicity and Safety of a Single 0.5 mL Dose of Inflexal V With a 0.25 mL 2-dose Regimen of Inflexal V

Who this might be right for
Influenza
Crucell Holland BV 205
Large-scale testing (Phase 3)Study completedNCT01310413
What this trial is testing

Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age

Who this might be right for
InfluenzaInfluenza Vaccines
GlaxoSmithKline 842
Early research (Phase 1)Study completedNCT00714285
What this trial is testing

Immunogenicity and Safety Study of a GSK Influenza Vaccine Candidate in Adults.

Who this might be right for
Influenza
GlaxoSmithKline 420
Testing effectiveness (Phase 2)Study completedNCT01561768
What this trial is testing

Evaluate the Immune Response and Safety of a Seasonal Virus-Like Particle Influenza Vaccine in Healthy Young Adults

Who this might be right for
Influenza
Novavax 500
Not applicableUnknownNCT04681950
What this trial is testing

Assessment of Self-Collected Sample Compared to Clinician Collected Sample in COVID-19 and Influenza Program

Who this might be right for
Subjects Possibly Exposed to COVID-19
Biocerna LLC 500
Testing effectiveness (Phase 2)Study completedNCT05823974
What this trial is testing

Assess the Safety and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults

Who this might be right for
Influenza, Human
GlaxoSmithKline 1,275
Post-approval studies (Phase 4)Looking for participantsNCT06841913
What this trial is testing

Woodsmoke Exposure, Influenza Infection, and Nasal Immunity

Who this might be right for
Smoke ExposureInfluenza
University of North Carolina, Chapel Hill 112
Testing effectiveness (Phase 2)UnknownNCT06254820
What this trial is testing

Dose, Safety, and Pathogenicity of a New Influenza B Strain

Who this might be right for
Influenza B
Hvivo 60
Large-scale testing (Phase 3)Study completedNCT06178991
What this trial is testing

Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza.

Who this might be right for
InfluenzaCOVID-19
BioNTech SE 8,795
Next Page